货号 | MAB774-SP |
别名 | CD153 antigen; CD153; CD30 antigen ligand; CD30-L; CD30LCD30 ligand; CD30LGMGC138144; TNFSF8; tumor necrosis factor (ligand) superfamily, member 8; tumor necrosis factor ligand superfamily member 8 |
反应种属 | Human |
应用 | Western Blot |
目标/特异性 | Detects human CD30 Ligand/TNFSF8 in direct ELISAs and Western blots. In Western blots, less than 1% cross‑reactivity with recombinant mouse CD30 Ligand is observed. |
使用方法 | Western Blot: 1 µg/mL |
来源 | Reconstitute at 0.5 mg/mL in sterile PBS. |
产品组分 |
供应商 | R&D Systems |
Entrez Gene IDs | 944 (Human); 21949 (Mouse) |
应用文献 | |
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions. A novel role for reciprocal CD30-CD30L signaling in the cross-talk between natural killer and dendritic cells. | |
纯化方式 | Protein A or G purified from ascites |
免疫原 | Mouse myeloma cell line NS0-derived recombinant human CD30 Ligand/TNFSF8 Gln63-Asp234 Accession # P32971 |
生物活性 | Human |
标记 | Unconjugated |
溶解方法 | Reconstitute at 0.5 mg/mL in sterile PBS. |
背景 | CD30 ligand (CD30L)/TNFSF8 is a type II membrane protein belonging to the TNF superfamily. CD30L is expressed on the cell surface of activated T cells, B cells, and monocytes. The protein is also constitutively expressed on granulocytes and medullary thymic epithelial cells. The specific receptor for CD30L is CD30/TNFRSF8, a type I transmembrane glycoprotein belonging to the TNF receptor superfamily. CD30 was originally identified as a cell surface antigen of Hodgkins and Reed-Sternberg cells using the monoclonal antibody Ki-1. CD30 is also expressed on different non-Hodgkins lymphomas, virus-infected T and B cells, and on normal T and B cells after activation. Among T cells, CD30 is preferentially expressed on a subset of T cells producing Th2-type cytokines and on CD4+/CD8+ thymocytes that co‑express CD45RO and IL-4 receptor. CD30 ligation by CD30L mediates pleiotropic effects including cell proliferation, activation, differentiation and cell death by apoptosis. CD30 can act as a co‑stimulatory molecule in thymic negative selection and may also play a critical role in the pathophysiology of Hodgkins disease and other CD30+ lymphomas. Human and mouse CD30 ligand cDNAs share 70% sequence homology. |
运输条件 | Blue Ice |
存放说明 | 4℃ |
参考文献 |
|